Literature DB >> 18395083

Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.

Giuseppe Mazzarella1, Rosita Stefanile, Alessandra Camarca, Paolo Giliberti, Elena Cosentini, Caterina Marano, Gaetano Iaquinto, Nicola Giardullo, Salvatore Auricchio, Alessandro Sette, Riccardo Troncone, Carmen Gianfrani.   

Abstract

BACKGROUND & AIMS: The extensive infiltration of CD8(+) T cells in the intestinal mucosa of celiac disease (CD) patients is a hallmark of the disease. We identified a gliadin peptide (pA2) that is selectively recognized by CD8(+) T cells infiltrating intestinal mucosa of HLA-A2(+) CD patients. Herein, we investigated the phenotype, the tissue localization, and the effector mechanism of cells responsive to pA2 by using the organ culture of CD intestinal mucosa. The target of pA2-mediated cytotoxicity was also investigated by using the intestinal epithelial cell lines Caco2 and HT29, A2(+) and A2(-), respectively, as target cells.
METHODS: Jejunal biopsy specimens from CD patients were cultured in vitro with pA2, and cellular activation was evaluated by immunohistochemistry and cytofluorimetric analysis. Cytotoxicity of pA2-specific, intestinal CD8(+) T cells was assayed by granzyme-B and interferon-gamma release and by apoptosis of target cells.
RESULTS: pA2 challenge of A2(+) CD mucosa increased the percentage of CD8(+)CD25(+) and of CD80(+) cells in the lamina propria, the former mainly localized beneath the epithelium, as well as the number of terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling-positive cells (TUNEL(+)) in the epithelium. Intraepithelial CD3(+) cells and enterocyte expression of Fas were also increased. CD8(+)CD25(+) and CD8(+)FASL(+) T cells were significantly increased in cell preparations from biopsy specimens cultured with pA2. CD8(+) T-cell lines released both granzyme-B and interferon-gamma following recognition of pA2 when presented by Caco2 and not by HT29.
CONCLUSIONS: These data indicate that gliadins contain peptides able to activate, through a TCR/HLA class I interaction, CD8-mediated response in intestinal CD mucosa and to induce the enterocyte apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395083      PMCID: PMC3319059          DOI: 10.1053/j.gastro.2008.01.008

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

Review 1.  Intraepithelial lymphocytes: exploring the Third Way in immunology.

Authors:  A Hayday; E Theodoridis; E Ramsburg; J Shires
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

Review 2.  CD28-mediated co-stimulation: a quantitative support for TCR signalling.

Authors:  Oreste Acuto; Frédérique Michel
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

3.  Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

Authors:  Bertrand Meresse; Zhangguo Chen; Cezary Ciszewski; Maria Tretiakova; Govind Bhagat; Thomas N Krausz; David H Raulet; Lewis L Lanier; Veronika Groh; Thomas Spies; Ellen C Ebert; Peter H Green; Bana Jabri
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

4.  Celiac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope.

Authors:  Carmen Gianfrani; Riccardo Troncone; Patrizia Mugione; Elena Cosentini; Mariateresa De Pascale; Clementina Faruolo; Stefania Senger; Giuseppe Terrazzano; Scott Southwood; Salvatore Auricchio; Alessandro Sette
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 5.  Coeliac disease: dissecting a complex inflammatory disorder.

Authors:  Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

6.  Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.

Authors:  Steffanie Sabbaj; Anju Bansal; G Douglas Ritter; Christopher Perkins; Bradley H Edwards; Ethan Gough; Jianming Tang; James J Szinger; Bette Korber; Craig M Wilson; Richard A Kaslow; Mark J Mulligan; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

7.  A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

Authors:  Sophie Hüe; Jean-Jacques Mention; Renato C Monteiro; ShaoLing Zhang; Christophe Cellier; Jacques Schmitz; Virginie Verkarre; Nassima Fodil; Seiamak Bahram; Nadine Cerf-Bensussan; Sophie Caillat-Zucman
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

8.  Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease.

Authors:  Jean-Jacques Mention; Mélika Ben Ahmed; Bernadette Bègue; Ullah Barbe; Virginie Verkarre; Vahid Asnafi; Jean-Frédéric Colombel; Paul-Henri Cugnenc; Frank M Ruemmele; Elisabeth McIntyre; Nicole Brousse; Chistophe Cellier; Nadine Cerf-Bensussan
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

9.  Alterations of the intestinal transport and processing of gliadin peptides in celiac disease.

Authors:  Tamara Matysiak-Budnik; Celine Candalh; Christophe Dugave; Abdelkader Namane; Christophe Cellier; Nadine Cerf-Bensussan; Martine Heyman
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 2.  Tissue-mediated control of immunopathology in coeliac disease.

Authors:  Bana Jabri; Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

3.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 4.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 5.  Pathogenesis of Enteropathy-Associated T Cell Lymphoma.

Authors:  Udit Chander; Rebecca J Leeman-Neill; Govind Bhagat
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

Review 6.  Type 1 diabetes and polyglandular autoimmune syndrome: A review.

Authors:  Martin P Hansen; Nina Matheis; George J Kahaly
Journal:  World J Diabetes       Date:  2015-02-15

7.  Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes.

Authors:  A I Lahdenperä; V Hölttä; T Ruohtula; H M Salo; L Orivuori; M Westerholm-Ormio; E Savilahti; K Fälth-Magnusson; L Högberg; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

8.  Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease.

Authors:  Anna Sapone; Karen M Lammers; Giuseppe Mazzarella; Irina Mikhailenko; Maria Cartenì; Vincenzo Casolaro; Alessio Fasano
Journal:  Int Arch Allergy Immunol       Date:  2009-11-24       Impact factor: 2.749

9.  Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease.

Authors:  Arnold Han; Evan W Newell; Jacob Glanville; Nielsen Fernandez-Becker; Chaitan Khosla; Yueh-Hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

10.  The thrombophilic network of autoantibodies in celiac disease.

Authors:  Aaron Lerner; Nancy Agmon-Levin; Yinon Shapira; Boris Gilburd; Sandra Reuter; Idit Lavi; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2013-04-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.